Ignite Creation Date:
2024-05-06 @ 11:43 AM
Last Modification Date:
2024-10-26 @ 12:49 PM
Study NCT ID:
NCT03583008
Status:
COMPLETED
Last Update Posted:
2019-03-21
First Post:
2018-06-26
Brief Title:
Supporting Use of AC Through Provider Profiling of Oral AC Therapy for AF
Sponsor:
University of Massachusetts Worcester
Organization:
University of Massachusetts Worcester
Study Overview
Official Title:
Supporting Use of AC Through Provider Profiling of Oral AC Therapy for AF
Status:
COMPLETED
Status Verified Date:
2019-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
SUPPORT-AF
Brief Summary:
The SUPPORT-AF study aims to improve rates of anticoagulation AC in atrial fibrillation AF patients by developing and delivering supportive tools and educational materials to providers treating patients with AF The investigators hypothesize that AC percentage will increase among providers receiving tools and educational content
Detailed Description:
Nearly 1 million patients with atrial fibrillation AF who meet guideline criteria for anticoagulation AC are being left untreated often due to providers over-estimating risks of bleeding and falling and under-estimating risks of stroke The objective of this project is to improve rates of adherence to AC guidelines by creating supportive and educational materials for cardiology as well as primary care providers to evaluate the risks and benefits of prescribing AC to patients with AF The investigators will email providers individual auto-updating reports containing their AC prescription rate compared to their peers and compared to practice level AC prescription goal This report will also contain a list of the providers AF patients who are eligible to receive AC based on their CHA2DS2-VASc stroke risk score 2 and a list of eligible AF patients with upcoming appointments to focus providers on an actionable group of patients with whom they might review the use of AC The investigators will also message providers through the EHR prior to an upcoming appointment with an eligible patient reminding them to discuss AC if they deem appropriate In addition the investigators will directly engage with providers through academic teledetailing to educate providers on AC and address misconceptions and barriers to initiating or resuming AC in AF patients
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None